Study shows that ablating the histone methyltransferase SUV39H1 enhances T cell memory/persistence, reduces T cell exhaustion, and provides protection against tumor relapses in mouse models PARIS, Nov. 7, 2023 /PRNewswire/ — Mnemo Therapeutics, a biotechnology company developing…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.